Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis.
Saved in:
| Title: | Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis. |
|---|---|
| Authors: | Chai S; Merck Research Laboratories (MRL) Global Medical Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China., Zhang R; Merck Research Laboratories (MRL) Global Medical Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China., Zhang Y; Merck Research Laboratories (MRL) Global Medical Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China., Carr RD; Hatter Cardiovascular Institute, University College London, UK and Ulster University, Coleraine, United Kingdom., Zheng Y; Merck Research Laboratories (MRL) Global Medical Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China., Rajpathak S; Merck Research Laboratories, Merck & Co., Inc., Rahway, NJ, United States., Ji L; Department of Endocrinology, People's Hospital of Peking University, Beijing, China. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Oct 12; Vol. 13, pp. 994944. Date of Electronic Publication: 2022 Oct 12 (Print Publication: 2022). |
| Publication Type: | Meta-Analysis; Systematic Review; Research Support, Non-U.S. Gov't; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36313782 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chai+S%22">Chai S</searchLink>; Merck Research Laboratories (MRL) Global Medical Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zhang+R%22">Zhang R</searchLink>; Merck Research Laboratories (MRL) Global Medical Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Merck Research Laboratories (MRL) Global Medical Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Carr+RD%22">Carr RD</searchLink>; Hatter Cardiovascular Institute, University College London, UK and Ulster University, Coleraine, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Zheng+Y%22">Zheng Y</searchLink>; Merck Research Laboratories (MRL) Global Medical Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Rajpathak+S%22">Rajpathak S</searchLink>; Merck Research Laboratories, Merck & Co., Inc., Rahway, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Ji+L%22">Ji L</searchLink>; Department of Endocrinology, People's Hospital of Peking University, Beijing, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101555782%22">Frontiers in endocrinology</searchLink> [Front Endocrinol (Lausanne)] 2022 Oct 12; Vol. 13, pp. 994944. <i>Date of Electronic Publication: </i>2022 Oct 12 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Meta-Analysis; Systematic Review; Research Support, Non-U.S. Gov't; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101555782 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-2392 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216642392%22">16642392 </searchLink><i>NLM ISO Abbreviation: </i>Front Endocrinol (Lausanne) <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36313782 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fendo.2022.994944 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 994944 Titles: – TitleFull: Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chai S – PersonEntity: Name: NameFull: Zhang R – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Carr RD – PersonEntity: Name: NameFull: Zheng Y – PersonEntity: Name: NameFull: Rajpathak S – PersonEntity: Name: NameFull: Ji L IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 10 Text: 2022 Oct 12 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 1664-2392 Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in endocrinology Type: main |
| ResultId | 1 |
